dfda compounded glp-1 receptor agonists Injections 𝗧𝗵𝗲 𝗘𝗳𝗳𝗲𝗰𝘁 𝗼𝗳 𝗚𝗟𝗣-𝟭 𝗥𝗲𝗰𝗲𝗽𝘁𝗼𝗿

GLP-1 drugs like Ozempic and Mounjaro may offer real benefits for people with type 1 diabetes: less insulin, flatter CGM curves, and emerging evidence for heart and kidney protection.

In response to shortages, the FDA allowed use of compounded GLP-1 drugs. What are “compounded drugs? Most prescription medications are approved by the FDA and manufactured by drug companies.Compoundeddrugs are made by licensed pharmacists or physicians who […]

Tirzepatide was approved in 2022 as Mounjaro for diabetes, and in 2024 as Zepbound for obesity, with exclusivity running until May 2027

Considerations regarding adverse effects and contraindications for different drug classes are provided to help guide treatment decision-making when considering pharmacotherapy for weight management in patients with obesity.

Yale Medicine experts explain who qualifies, who can prescribe, and what to expect.

Supplement Facts: GLP-1 Support Blend 650 mg